Reston, VA; July 23, 2013– Manufacturers in the pharmaceutical, biopharmaceutical, nutraceutical and medical device industries are facing significant challenges in 2013,
Hydrocortisone inhibits prostaglandin synthesis by inhibiting the enzyme phospholipase A2. Hydrocortisone reduces various vasoactive agents released during inflammation. It also controls
Bromazepam is a pyridylbenzodiazepine compound with anxiolytic properties. In low dosage, it diminishes anxiety, tension and nervousness. In high dosage, the